The pharmacokinetics of bumetanide in the newborn infant

Neonatology

Volumn 72, Issue 5, 1997, Pages 265-272

  Lopez Samblas, Ana M ^a,c   Adams, Jose A ^a,b   Adams, Ronald N ^a,b   Modi, Marlene W ^a,d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Newborn Intensive Care Unit   (United States)

^c Children's Hospital   (United States)

^d HOFFMANN LA ROCHE INC   (United States)

Author keywords

Bumetanide; Diuretic; Neonate; Pharmacokinetics; Premature infant

Indexed keywords

BUMETANIDE; DRUG METABOLITE; LOOP DIURETIC AGENT;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG URINE LEVEL; GESTATIONAL AGE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN; OTOTOXICITY; PREMATURITY; PRIORITY JOURNAL;

BUMETANIDE; DIURETICS; HUMANS; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; TIME FACTORS;

EID: 0030720279     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000244492     Document Type: Article

References (18)

1. Wells TG: The pharmacology and therapeutics of diuretics in the pediatric patient, Pediatr Clin North Am 1990;37:463-504.
2. Ward A, Heel RC: Bumetanide: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use, Drugs 1984:28: 426-464.
3. Brater DC: Disposition and response to bumetanide and furose-mide, Am J Cardiol 1986;57:20A-25A.
4. Morsclli PL: Clinical pharmacology of the perinatal period and early infancy, Clin Pharmacokinet 1989; 17(suppl 1): 13-28.
5. Witte M, Rudloff A, Yamashita T, Blumer J: Dose ranging pharmacokinetics (PK) and pharmacodynamic (PD) evaluation of bumetanide (B) in infants with volume overload (VO), Acta Pharmacol Toxicol 1986;59(suppl 5): 152.
6. Shankaran S, Ilagan N, Liang K-C, Bhavsar V, Kauffman R: Bumetanide pharmacokinetics in preterm neonates, Clin Res 1989;37:956A.
7. Walker PC, Ezhuthachan S, Dcsai R: Effects of single dose bumetanide in premature neonates, Pediatr Res 1988;23:265A.
8. Wells TG, Fasules JW, Taylor BJ, Kearn GL: Pharmacokinetics and pharmacodynamics of bumetanide in neonates treated with cxtracor-porcal membrane oxygenation, J Pediatr 1992; 121:974-980.
9. Dubowitz LMS, Dubowitz V, Goldberg C: Clinical assessment of gestational age in the newborn infant, J Pediatr 1970;77:1-10.
10. Smith DE: High-performance liquid chromatographic assay for bumeta-nide in plasma and urine, J Pharnt Sci 1982;71:520-523.
11. Gibaldi M, Perrier D: Noncompart-mental analysis based on statistical moment theory; in Swarbrick J: Pharmacokinetics, Drugs and the Pharmaceutical Sciences, cd 2. New York, Dekker, 1982. vol 15. pp 409-417.
12. Aranda JV, Chemtob S, Laudignon N, Sasyniuk BI: Furosemidc and vitamin E, Two problem drugs in neonatology, Pediatr Clin North Am 1986;33:583-602.
13. Ward OC, Lam LKT: Bumetanide in heart failure in infancy, Arch Dis Child 1977;52:877-882.
14. Cook JA, Smith DE, Cornish LA, Tankanow RM, Nicklas JM, Hy-ttcck ML: Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with congestive heart failure, Clin Pharmacol Ther 1988;44:487-500.
15. Besunder JB, Reed MD, Blunter JL: Principles of drug disposition in the neonate: A critical evaluation of the pharmacokinetics-pharmacodynamic interface (part I), Clin Pharmacokinet 1988;14:189-216.
16. UC]-bumetanide in man, Br J Clin Pharmacol 1977;4:39-44.
17. Halladay SC, Sipes IG, Carter DE: Diuretic effect and metabolism of bumetanide in man, Clin Pharmacol Ther 1977;22:179-187.
18. Kraus DM, Fischer JH, Reitz SJ, Kecskes SA, Yeah TF, McCulloch KM, Tung EC, Cwik MJ: Alterations in theophylline metabolism during the first year of life, Clin Pharmacol Thcr 1993;54:351-359.